Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference
Tuesday, March 4, 2025 1 min read
Key Takeaway: Regulus Therapeutics Inc. will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference on March 11, 2025. The event will be accessible live and will also be archived for 90 days. Regulus focuses on developing innovative medicines targeting microRNAs and has a strong intellectual property portfolio.
Market Sentiment Analysis
POSITIVE FACTORS
Regulus Therapeutics is actively engaging with investors.
The company is focused on innovative medicines targeting microRNAs.
Participation in a prominent healthcare conference highlights their visibility.
Full Press Release Details
SAN DIEGO,March 4, 2025/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq:RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that members of the management team will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference onTuesday, March 11that3:40 p.m. ET.
The live event and replay of the presentation will be available under "Events and Presentations" through the investor relations section of the Company's website athttps://ir.regulusrx.com/eventsand archived for 90 days following the presentation date.
About RegulusRegulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters inSan Diego, CA.
SOURCE Regulus Therapeutics Inc.
Frequently Asked Questions
When will Regulus Therapeutics present at the conference?
Regulus Therapeutics will present on March 11, 2025, at 3:40 p.m. ET.
Where can I watch the Regulus presentation?
The presentation will be available on Regulus' investor relations website.
What is the focus of Regulus Therapeutics?
Regulus focuses on developing innovative medicines targeting microRNAs.
How long will the presentation be archived?
The presentation will be archived for 90 days after the event.